Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 0 | 2,608,419 | +2,608,419 | $0 | $144.30M | 29.03% | +$144.30M |
| Vir Biotechnology, Inc.(VIR) | 0 | 8,550,954 | +8,550,954 | $0 | $95.60M | 19.23% | +$95.60M |
| Wave Life Sciences IncSHS | 0 | 18,245,691 | +18,245,691 | $0 | $67.51M | 13.58% | +$67.51M |
| BioNTech SEADS(BNTX) | 0 | 668,526 | +668,526 | $0 | $65.72M | 13.22% | +$65.72M |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 1,333,333 | +1,333,333 | $0 | $51.23M | 10.31% | +$51.23M |
| Cytokinetics, Incorporated(CYTK) | 0 | 340,434 | +340,434 | $0 | $22.44M | 4.51% | +$22.44M |
| Lyell Immunopharma Inc | 0 | 1,512,659 | +1,512,659 | $0 | $14.81M | 2.98% | +$14.81M |
| Spero Therapeutics Inc | 0 | 9,190,606 | +9,190,606 | $0 | $11.12M | 2.24% | +$11.12M |
| Nkarta Inc | 0 | 3,150,732 | +3,150,732 | $0 | $8.25M | 1.66% | +$8.25M |
| Fulcrum Therapeutics Inc | 0 | 1,785,714 | +1,785,714 | $0 | $6.61M | 1.33% | +$6.61M |
| Bicycle Therapeutics PlcADS | 0 | 1,529,561 | +1,529,561 | $0 | $5.63M | 1.13% | +$5.63M |
| Regenxbio Inc | 0 | 271,456 | +271,456 | $0 | $2.04M | 0.41% | +$2.04M |
| Cvrx Inc | 0 | 1,007,583 | +1,007,583 | $0 | $1.76M | 0.35% | +$1.76M |